Kathy Y. Yi

Overview

Kathy Y. Yi received an average of $1M in total compensation, including $292K in salary, at Sangamo Biosciences from 2017 to 2019.

Source: SEC filings on April 1, 2020 and April 24, 2018.

Related executives

We found 18 more executives who work or worked at Sangamo Biosciences.

Alexander Macrae

Sangamo Biosciences

Chief Executive Officer

Robert Schott

Sangamo Biosciences

Senior Vice President, Head of Development

R Ramelmeier

Sangamo Biosciences

Executive Vice President, Technical Operations

D McClung

Sangamo Biosciences

Chief Operating Officer

Prathyusha Duraibabu

Sangamo Biosciences

Chief Financial Officer

Sung Lee

Sangamo Biosciences

Chief Financial Officer

Stéphane Boissel

Sangamo Biosciences

Former Executive Vice President, Corporate Strategy

Gary Loeb

Sangamo Biosciences

General Counsel

News

You may also like